Substituted quinazolines as kinase inhibitors
US9359349B2 · kind B2 · utility
55Cited by
152References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 19, 2014 |
| Grant date | Jun 7, 2016 |
| Priority date | — |
| Expiry date | Sep 19, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula Ithat modulate PI3 kinase activity and methods of treatment of diseases and conditions associated with PI3 kinase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.